Jazz Pharmaceuticals plc — Director's Dealing 2016

Dec 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-12-15

Reporting Person: MILLER MICHAEL PATRICK (SVP, US Commercial)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-15	Ordinary Shares	S	200	$103.09	Disposed	16886	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 161 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2016.